GoodRx (GDRX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov6

BofA Securities Reiterates GoodRx Holdings Sell Rating With $3.40 Price Target

11:38

Nov5

GoodRx released FY2025 Q3 earnings on November 4 After-Market (EST), actual revenue USD 196.03 M (forecast USD 194.51 M), actual EPS USD 0.0032 (forecast USD 0.035)

00:00

GoodRx released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 602.07 M and EPS of USD 0.0683

00:00

Oct29

GoodRx to Report Q3 2025 Earnings on November 4

13:54

Oct28

GoodRx to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 194.51 M, EPS USD 0.035

00:14

Oct15

GoodRx Launches Subscription Service for Male Hair Loss Treatment

14:02

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 196.03 M, Net Income 1.119 M, EPS 0.0032

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 203.07 M, Net Income 12.84 M, EPS 0.036

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 202.97 M, Net Income 11.05 M, EPS 0.0291

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change